February 6, 2020 / 9:32 PM / 18 days ago

BRIEF-Ligand Reports Q4 Adjusted Earnings Per Share $0.71

Feb 6 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.43

* Q4 REVENUE $27 MILLION VERSUS REFINITIV IBES ESTIMATE OF $25.2 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $0.64 — REFINITIV IBES DATA

* SEES FY 2020 REVENUE ABOUT $121 MILLION

* ADJUSTED EARNINGS PER DILUTED SHARE WOULD BE APPROXIMATELY $3.40 FOR 2020

* FY2020 EARNINGS PER SHARE VIEW $3.50, REVENUE VIEW $124.6 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below